Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Effective treatments for severe alopecia areata are still lacking.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Non-immune factors play a significant role in alopecia areata.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.